CytomX Therapeutics Intangible Assets

CytomX Therapeutics (CTMX) currently reports a intangible assets of $370K as of June 2026. That compares with $510K in the prior-year period — down 28.4% year over year. Use the charts on this page to explore CytomX Therapeutics's intangible assets history and peer comparisons.

CytomX Therapeutics's intangible assets decreased from $510K to $370K — a 28.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CytomX Therapeutics reported $370K in intangible assets as of June 2026. That compares with $510K in the prior-year period — down 28.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $370K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CytomX Therapeutics, and consider following CTMX for alerts when major investors trade the stock.

CytomX Therapeutics is classified in the Healthcare sector. On intangible assets, it currently shows $370K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTMX with unrelated industries.